New Delhi: A drug for hair loss used by US President Donald Trump has been linked to an increased risk of depression, anger, self-harm and erectile dysfunction.
According to a new study, the drug Finasteride can also cause many serious and uncomfortable side effects.
It is also widely believed that the reducing drug of the prostate is a significant factor that affects the president's low PSA (prostate) and thick hair levels.
A study published in March 2017 by Western University in Ontario showed concrete evidence regarding the mental health risks of the pills and seemed to confirm the fear of many doctors that it increases the risk of suicidal tendencies.
The same week, another study conducted by the Feinberg School of Medicine at Northwestern University found that most of the participants who took the drug remained impotent for four years.
Finasteride, originally developed to treat urinary problems in men, belongs to a class of drugs known as 5-alpha-reductase inhibitors (5ARI).
Studies show that the drug reduced the prostate glands by reducing the levels of the hormone dihydrotestosterone in the participants.
However, in recent years, the 5ARIs have come under increasing scrutiny from US and Canadian regulators because of a possible link to mental health problems, the researchers said, Mailonline reports.
During clinical trials, the scientist discovered an unexpected side effect: hair growth.
And in 1997, the FDA approved the steroid inhibitor as the first drug to treat male pattern baldness.
Finasteride, which is sold primarily under the brand name Propecia, is taken once a day.
Pills used by millions of American adults have been shown to be 90 percent effective.
It should be noted that in February 2017, Trump doctor Harold Bornstein had revealed in an interview that the president takes a small dose of finasteride to stimulate hair growth.
Bornstein also tells The New York Times that he also takes the drug, adding that it helped him keep his locks up to his shoulders and helped Trump maintain his own hair.
Finasteride reduces PSA levels to reduce inflammation of the prostate glands.
Men aged 60-69 years, usually finasteride is given between 4.0 and 5.0ng / ml, which is higher than younger men since the levels of PSA and testosterone increase with age.
But the number may be lower than normal if a man has prostate cancer or inflammation, causing more PSA to leak into the bloodstream.
(With entries from the Agency)